MIRA
INFORM REPORT
|
Report Date : |
09.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
JEAN-MARIE PHARMACAL CO LTD |
|
|
|
|
Registered Office : |
1fl Tai Po
Industrial Estate - Gmp Centre 12 Dai Fu St Tai Po New Territories |
|
|
|
|
Country : |
Hong Kong. |
|
|
|
|
Date of Incorporation : |
21.02.1978 |
|
|
|
|
Com. Reg. No.: |
0058492 |
|
|
|
|
Legal Form : |
Private |
|
|
|
|
Line of Business : |
Manufacturing and Exporting different dosage forms such as tablets,
capsules, liquids, creams, eye-drops,
ear-drops and sterile injections |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
JEAN-MARIE PHARMACAL CO LTD
1FL TAI PO INDUSTRIAL ESTATE - GMP CENTRE 12 DAI FU ST
TAI PO NEW TERRITORIES, HONG KONG.
TEL: 852-24073271 FAX: 852-24075707
EXECUTIVE SUMMARY
INCORPORATION DATE : FEBRUARY 21, 1978
REGISTRATION NO. : 0058492
LEGAL FORM : PRIVATE
CHIEF EXECUTIVE : MR. LAM (ASSIST GENERAL MANAGER)
STAFF STRENGTH : 80
CAPITAL : US$ 128,041
BUSINESS LINE : MANUFACTURER
TURNOVER : N/A (AS OF DEC. 31, 2005)
EQUITIES : N/A (AS OF DEC. 31, 2005)
PAYMENT : AVERAGE
RECOMM. CREDIT RANGE : UP TO USD 65,000
MARKET CONDITION : COMPETITIVE
FINANCIAL CONDITION : STEADY
OPERATIONAL TREND : STABLE
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : HKD 7.81625 = US$1 AS OF 2007-4-6
history
*Company History*
===============
1997 - Became subsidiary of TUNG FONG HUNG INVESTMENT LTD.
20 January, 2003 - Declared "Nano-Technology Anti-Microbial Socks".
15 May, 2003 - Declared "JMP Instant Disinfectant" and "Nano-Technology Anti-Bacterial Face Mask".
28 April, 2003 - Declared "Jean-Marie Nanotechnology Anti-bacterial Face Mask".
*Company Registration*
===================
(1)
License number : 0058492
Date issued : 21 February, 1978
Issuing authority : Companies Registry
Legal form : Private Limited Company
Type of license : Corporate
(2)
License number : 05528392-000
Date issued : N/A
Issuing authority : Business Registration Office - Inland Revenue Dept
Type of license : Business
(3)
License number : 05528392-003
Date issued : N/A
Issuing authority : Business Registration Office - Inland Revenue Dept
Type of license : Business
*Capital Details*
=============
Share value : HKD 1.00/-each
Authorized capital : HKD 1,000,000.00
Paid-up capital : HKD 812,600.00 divided into 812,600 ordinary shares
*Factories, Size & Locations*
=======================
Size : 8,000 sq meters
Facility : State of the art pharmaceutical GMP production facility
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation within the respective industry failed to reveal any negative information.
*Approved Signatures*
==================
Ms. Winnie Wai-han Lai can sign on behalf of the company with seal affixed.
website
www.jmp.com.hk
The design is professional and the content is well organized. At present it is
both in Chinese and English versions.
E-mail: jm@jmp.com.hk
Litigation
For the past two years there is no record of litigation.
Ownership/management
background
*Major Shareholders*
=================
Shareholder's Name
--------------------------
TUNG FONG HUNG INVESTMENT LTD
*Directors' Details*
===============
(1)
M/s. Winnie Wai-han Lai
HKID no. : G409686(9)
Address : Flat A2, 5Fl Fairland Garden 7 Homantin Hill Rd, Kowloon Hong Kong
(2)
Mr. Calvin Ka-ho Yu
HKID no. : K709410(8)
Address : Flat 7E Block 4 Beacon Heights Lung Ping Rd, Kowloon Hong Kong
*Company Secretary*
=================
TFH MANAGEMENT LTD
License number : 606844
Address : Ground Fl Tai Po Industrial Estate - GMP Centre 12 Dai Fu St Tai Po New Territories Hong Kong
Management
Management: Mr. Lam, Assist. General Manager
Name Nationality Job Description
Mr. Lam Hong Kong Assist. General Manager
Business operation
*Main Products & Services*
======================
Specializes in manufacturing and exporting over 400 different types of registered drug products including prescription drugs and over-the-counter (OTC) products with a total of six production lines, manufacturing different dosage forms such as tablets, capsules, liquids, creams, eye-drops, ear-drops and sterile injections.
Products: Medicated powders
Medicines
Ointments
OTC (over-the-counter) product
Oral liquid
*Brand*
=======
A-D Cal
Acilax
Actimex
Allopurinol
Amiloride
Amithiazide
Arti-Drine
Asmalin
Beclomin
Beta
Broom P P
Busopin
Calcium Carbonate
Cepticura
Chorpheniramine
Cimeta
Clobasol
Clomiphene Citrate
Clotrinolon
Clozole
Clozole Vaginal
Colcina
Crema-U
Dermojela Gel
Dextrophen+Paracetam
Diclofen
Dimenhydrinate
Diprophylline
Disclofen
Eurosin
Famolta
Fendyl
Folax
Griseofulvin
Hypo
Influ
Jean-Marie
Jem C P P
Lapril
Lopa
Lotadine
Lysozyme
Mefa
Methyldopa
Neo-Meton
Oragesic Gel
Petina Compound
Prochlorperazine
Ranolta
Redusa
Sinuton
Sleep-Qik
Sterile Liquid Paraf
Ticomona-200
Tolnin
Tyrothricin Co
Valencia
Vastin
Vibion (Strong)
Zomin
*Payment Terms*
==============
Sales
-------
Local : Cash or Credit
Export : Letter of Credit (L/C)
Telegraphic Transfer (T/T)
Purchases
--------------
Local : Cash or Credit
*Exhibition Participation*
====================
Exhibition fair : 37th Hong Kong Product Expo
Dates attended : 14 December, 2002
Location : Tamar Site Hong Kong
*Associations*
============
Member of:
- Federation of Hong Kong Industries
*Local Distribution Network*
=======================
Part of the annual turnover is attributed to local sales.
*Export Markets*
==============
Majority of the annual turnover is attributed to export.
Related Companies
*(Subsidiaries , Joint-ventures & Affiliates)
===============================
Company Name : PACIFIC WINS DEVELOPMENT LTD
Country : Hong Kong
Relationship : Affiliate
Legal Form : Private Limited Company
Company Type : Service
Industry : Professional Services
Company Name : TUNG FONG HUNG MEDICINE CO LTD
Address : Ground Fl Tai Po Industrial Estate - GMP Centre 12 Dai Fu St Tai Po New Territories Hong Kong
Country : Hong Kong
Relationship : Affiliate
Legal Form : Private Limited Company
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Payment
PAYMENT RATING :3 OBTAINED SCORES : 53
|
Rating Key |
Implication |
Implications |
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating
indicates the payment pattern of SC based upon our Payment Database, comments
from suppliers of SC, information from banks (if available), as well as
industrial sources.
Dealings on
open terms may be possible for MODERATE amounts depending on individual
judgement experience.
Financial Highlights
As a private limited company there is no legal requirement according to local corporate law for public disclosure of detailed financials.
*BANK DETAILS*
================
Bank Name : BANK OF CHINA (HONG KONG) LTD
Global Identifier : 30405519
Branch : Central,Hong Kong
Branch Address : 13Fl Bank Of China Tower 1 Garden Rd Central Hong Kong (Head Office)
SWIFT Code : BKCHHKHH
Bank Name : HANG SENG BANK LTD
Global Identifier : 30400428
Branch : Central,Hong Kong
Branch Address : Level 21 Hang Seng Bank Bldg 83 Des Voeux Rd Central Hong Kong (Head Office)
SWIFT Code : SCBLHKHH
Remark
Over the past 29 years, SC has made a stable growth with satisfactory profit. It is considered a credit line up to USD 65,000 appears to be within SC’s capacities.
SIC
PRODUCT CLASSIFICATION & ACTIVITY
Activity
Code Product/Service Description
Exporting 2833
Medicinals and botanicals
Exporting 2834
Pharmaceutical preparations
Exporting 5047
Medical/Dental
Equip/Supplies
Exporting 5122
Drugs/Druggists' Sundries
Manufacturing 2833
Medicinals and botanicals
Manufacturing 2834
Pharmaceutical preparations
Manufacturing 5047
Medical/Dental
Equip/Supplies
Manufacturing 5122
Drugs/Druggists' Sundries
HARMONIZED
PRODUCT CLASSIFICATION & ACTIVITY
Activity
Code Product/Service Description
Exporting 2934302700
Other drugs,
Exporting 3000
Pharmaceutical products
Exporting 3003
Medicaments of mixtures,
not dosage etc form
Exporting 3004
Medicaments, mixed or not,
in dosage etc form
Exporting 3006
Pharmaceutical goods
(specified sterile prod etc.)
Manufacturing 2934302700
Other drugs,
Manufacturing 3000
Pharmaceutical products
Manufacturing 3003
Medicaments of mixtures,
not dosage etc form
Manufacturing 3004
Medicaments, mixed or not,
in dosage etc form
Manufacturing 3004909010
Other anti-infective medicaments not
elsewhere specified or included
DETAILED
PRODUCT CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Exporting Parapharmaceutical
preparation
Exporting Pharmaceutical
creams
Exporting Prescription
drug
Exporting Therapeutic
drugs
Exporting Pharmaceutical
products
Exporting Pharmaceutical
Exporting Over-the-counter
medications
Manufacturing Eye
drops
Manufacturing Film-coated
tablets
Manufacturing Injection
INTERNATIONAL
TRADE : ACTIVITY & MARKETS
Exporting to Africa
Exporting to Asia
Exporting to China
Exporting to Macau
Exporting to Nigeria
Exporting to North America
Exporting to Philippines
Exporting to USA
Exporting to United Kingdom
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)